Curi RMB Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-157,696
| Closed | -$525K | – | 669 |
|
|
2025
Q1 | $525K | Buy |
157,696
+49,059
| +45% | +$163K | 0.01% | 381 |
|
|
2024
Q4 | $804K | Hold |
108,637
| – | – | 0.02% | 360 |
|
|
2024
Q3 | $1.02M | Buy |
108,637
+36,117
| +50% | +$339K | 0.02% | 337 |
|
|
2024
Q2 | $582K | Sell |
72,520
-250
| -0.3% | -$2.01K | 0.01% | 399 |
|
|
2024
Q1 | $1.08M | Buy |
72,770
+1,953
| +3% | +$28.9K | 0.02% | 337 |
|
|
2023
Q4 | $576K | Buy |
70,817
+1,000
| +1% | +$8.13K | 0.02% | 372 |
|
|
2023
Q3 | $318K | Buy |
69,817
+35,026
| +101% | +$159K | 0.01% | 425 |
|
|
2023
Q2 | $245K | Hold |
34,791
| – | – | 0.01% | 461 |
|
|
2023
Q1 | $213K | Hold |
34,791
| – | – | 0.01% | 470 |
|
|
2022
Q4 | $222K | Hold |
34,791
| – | – | 0.01% | 447 |
|
|
2022
Q3 | $333K | Hold |
34,791
| – | – | 0.01% | 398 |
|
|
2022
Q2 | $384K | Hold |
34,791
| – | – | 0.01% | 384 |
|
|
2022
Q1 | $579K | Buy |
34,791
+7,453
| +27% | +$124K | 0.02% | 318 |
|
|
2021
Q4 | $522K | Hold |
27,338
| – | – | 0.02% | 353 |
|
|
2021
Q3 | $674K | Hold |
27,338
| – | – | 0.02% | 316 |
|
|
2021
Q2 | $711K | Hold |
27,338
| – | – | 0.02% | 318 |
|
|
2021
Q1 | $866K | Hold |
27,338
| – | – | 0.03% | 282 |
|
|
2020
Q4 | $1.27M | Hold |
27,338
| – | – | 0.05% | 281 |
|
|
2020
Q3 | $900K | Sell |
27,338
-3,468
| -11% | -$114K | 0.04% | 313 |
|
|
2020
Q2 | $846K | Buy |
30,806
+125
| +0.4% | +$3.43K | 0.04% | 317 |
|
|
2020
Q1 | $918K | Sell |
30,681
-12
| -0% | -$359 | 0.04% | 298 |
|
|
2019
Q4 | $850K | Buy |
30,693
+5,487
| +22% | +$152K | 0.02% | 366 |
|
|
2019
Q3 | $459K | Buy |
+25,206
| New | +$459K | 0.01% | 471 |
|